Heart ultrasound gets a boost: new contrast agent aims for sharper images
Diagnosis
Ongoing
This Phase 3 trial tests whether NH002, a contrast agent made of tiny gas-filled microspheres, can improve the quality of heart ultrasound images in people with heart disease. Participants receive NH002 through an IV before a standard echocardiogram. The study compares the clarit…
Phase: PHASE3 • Sponsor: Trust Bio-sonics, Inc. • Aim: Diagnosis
Last updated Jul 11, 2026 00:00 UTC